Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:39123454

Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as Potential New Biomarkers in Patients with Diabetes Mellitus and Pancreatic Adenocarcinoma.

Theodoros Kolokotronis · Britta Majchrzak-Stiller · Marie Buchholz · Vanessa Mense · Johanna Strotmann · Ilka Peters · Lea Skrzypczyk · Sven-Thorsten Liffers · Louise Massia Menkene · Mathias Wagner · Matthias Glanemann · Fay Betsou · Wim Ammerlaan · Ronny Schmidt · Christoph Schröder · Waldemar Uhl · Chris Braumann · Philipp Höhn

Cancers · 2024 doi:10.3390/cancers16152726

Paper

complete

Experiment

partial

Data

partial

Analysis

complete

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:39123454
kind
science-record
content_hash
sha256:40868038158a6ae2b0b541bea9fcfb926c08ead5756f649bbccfc62ae2f8ef44
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T20:29:13Z
updated_at
2026-11-01T22:54:54Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as Potential New Biomarkers in Patients with Diabetes Mellitus and Pancreatic Adenocarcinoma.
doi
10.3390/cancers16152726
pmid
39123454
authors array · 18 items
[0]
Theodoros Kolokotronis
[1]
Britta Majchrzak-Stiller
[2]
Marie Buchholz
[3]
Vanessa Mense
[4]
Johanna Strotmann
[5]
Ilka Peters
[6]
Lea Skrzypczyk
[7]
Sven-Thorsten Liffers
[8]
Louise Massia Menkene
[9]
Mathias Wagner
[10]
Matthias Glanemann
[11]
Fay Betsou
[12]
Wim Ammerlaan
[13]
Ronny Schmidt
[14]
Christoph Schröder
[15]
Waldemar Uhl
[16]
Chris Braumann
[17]
Philipp Höhn
journal
Cancers
year
2024
abstract
Early detection of PDAC remains challenging due to the lack of early symptoms and the absence of reliable biomarkers. The aim of the present project was to identify miRNA and proteomics signatures discriminating PDAC patients with DM from nondiabetic PDAC patients. Proteomics analysis and miRNA array were used for protein and miRNA screening. We used Western blotting and Real-Time Quantitative Reverse Transcription polymerase chain reaction (qRT-PCR) for protein and miRNA validation. Comparisons between experimental groups with normal distributions were performed using one-way ANOVA followed by Tukey's post hoc test, and pairwise tests were performed using t-tests. p ≤ 0.05 was considered statistically significant. Protein clusters of differentiation 166 (CD166), glycoprotein CD63 (CD63), S100 calcium-binding protein A13 (S100A13), and tumor necrosis factor-β (TNF-β) were detected in the proteomics screening. The miRNA assay revealed a differential miRNA 1285 regulation. Previously described target proteins of miR-1285 cadherin-1 (CDH-1), cellular Jun (c-Jun), p53, mothers against decapentaplegic homolog 4 (Smad4), human transglutaminase 2 (TGM2) and yes-associated protein (YAP), were validated via Western blotting. miR-1285-3p was successfully validated as differentially regulated in PDAC + DM via qRT-PCR. Overall, our data suggest miRNA1285-3p, TGM2, CDH-1, CD166, and S100A13 as potential meaningful biomarker candidates to characterize patients with PDAC + DM. Data are available via ProteomeXchange with the identifier PXD053169.
claims array · 3 items
[0] object · 6 fields
id
claim-method
statement
Comparisons between experimental groups with normal distributions were performed using one-way ANOVA followed by Tukey’s post hoc test, and pairwise tests were performed using unpaired t-tests. A linear model was fitted to the normalized data, and differential expression was assessed by computing the empirical Bayes statistics.
kind
methodological
target
null
evidence array · 2 items
[0] object · 3 fields
asset
source:pmid:39123454
locator
sections[12] "2.7. Statistics and Calculations" paragraph 2
quote
Comparisons between experimental groups with normal distributions were performed using one-way ANOVA followed by Tukey’s post hoc test, and pairwise tests were performed using unpaired t-tests.
[1] object · 3 fields
asset
source:pmid:39123454
locator
sections[8] "2.3.3. miRNA Profiling Using a Takara Platform" paragraph 2
quote
A linear model was fitted to the normalized data, and differential expression was assessed by computing the empirical Bayes statistics.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
The mass spectrometry proteomics data that support the findings of this study have been deposited to the ProteomeXchange Consortium via the PRIDE [1] partner repository with the dataset identifier PXD053169. Our data are available upon reasonable request.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:39123454
locator
sections[26] "notes" paragraph 1
quote
The mass spectrometry proteomics data that support the findings of this study have been deposited to the ProteomeXchange Consortium via the PRIDE [1] partner repository with the dataset identifier PXD053169. Our data are available upon reasonable request.
state
complete
[2] object · 6 fields
id
claim-target-result
statement
miRNA-1285 was selected for validation because it had a logFC of 1.25 and was significantly expressed in both resected and unresectable PDAC subgroups.
kind
qualitative
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:39123454
locator
sections[16] "3.3. miRNA Microarray Results and Selection of miRNA Targets" paragraph 4
quote
miRNA-1285 with a logFC of 1.25 was selected as the most promising miRNA for validation, as it was significantly expressed in both subgroups of patients with resected and unresectable PDAC.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
partial
objective
miRNA-1285 was selected for validation because it had a logFC of 1.25 and was significantly expressed in both resected and unresectable PDAC subgroups.
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:39123454
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
blocked
blocked_on
data:accession_unresolved
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:PXD053169
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:PXD053169
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 1 item
[0]
step:obtain_source_data blocked on data:accession_unresolved
data object · 3 fields
state
partial
assets array · 2 items
[0] object · 15 fields
id
source:pmid:39123454
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.3390/cancers16152726
sha256
sha256:391a5a63d5a3a4ed2e5f2ba587a7c11990d2fd521cdcb66389933608bc9d6356
bytes
61916
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.3390/cancers16152726
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC11311671
source
europe_pmc_fulltext
coverage
whole_body_without_references
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:PXD053169
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD053169
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
PXD053169
version
null
note
The mass spectrometry proteomics data that support the findings of this study have been deposited to the ProteomeXchange Consortium via the PRIDE [1] partner repository with the dataset identifier PXD053169. Our data are available upon reasonable request.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
The mass spectrometry proteomics data that support the findings of this study have been deposited to the ProteomeXchange Consortium via the PRIDE [1] partner repository with the dataset identifier PXD053169. Our data are available upon reasonable request.
access_statement_kind
data_availability_statement
sample_accessions array · 0 items
sample_count
null
group_sizes
null
group_sizes_basis
null
platform
null
taxon
null
title
null
resolution_checked_at
2026-11-01T20:16:17Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
gaps array · 2 items
[0]
asset:data:geo:PXD053169 not downloaded
[1]
asset:data:geo:PXD053169 licence not read
analysis object · 4 fields
state
complete
methods array · 1 item
[0] object · 10 fields
id
method-1
family
group_comparison
specific
anova
label
Group comparison
dsl_operations array · 4 items
[0]
group_summary
[1]
welch_t
[2]
bootstrap_mean_difference
[3]
group_comparison_anova
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
two_or_more_groups_continuous
evidence object · 3 fields
score
1
band
reordered
quote
Comparisons between experimental groups with normal distributions were performed using one-way ANOVA followed by Tukey’s post hoc test, and pairwise tests were performed using unpaired t-tests. A linear model was fitted to the normalized data, and differential expression was assessed by computing the empirical Bayes statistics.
targets array · 0 items
gaps array · 0 items
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
blocked
tier
R4
blocked_on
data:accession_absent
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
true
required_operations array · 4 items
[0]
group_summary
[1]
welch_t
[2]
bootstrap_mean_difference
[3]
group_comparison_anova
missing_operations array · 0 items
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: anova.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R4
reachable
false
accessions array · 1 item
[0]
PXD053169
resolved_accessions array · 0 items
statements array · 1 item
[0]
The mass spectrometry proteomics data that support the findings of this study have been deposited to the ProteomeXchange Consortium via the PRIDE [1] partner repository with the dataset identifier PXD053169. Our data are available upon reasonable request.
basis
The paper names PXD053169, but the accession does not resolve in the repository (not_in_proteomexchange), so the data cannot be reached from here. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 4 items
[0]
group_summary
[1]
welch_t
[2]
bootstrap_mean_difference
[3]
group_comparison_anova
assets array · 2 items
[0]
source:pmid:39123454
[1]
data:geo:PXD053169
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:PXD053169
gaps array · 1 item
[0]
data:accession_absent
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-11-01T19:27:24Z
independence
single_reader
evidence_check object · 2 fields
method
reordered
availability
verbatim
calls
5
usage object · 3 fields
prompt_tokens
16549
completion_tokens
1715
cached_tokens
256
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:39123454
type
paper
label
pmid:39123454
[1] object · 3 fields
id
source:pmid:39123454
type
manuscript
label
PMID 39123454 full text
[2] object · 3 fields
id
data:geo:PXD053169
type
dataset
label
GEO PXD053169
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:39123454
type
paper
label
pmid:39123454
[1] object · 3 fields
id
source:pmid:39123454
type
manuscript
label
PMID 39123454 full text
[2] object · 3 fields
id
data:geo:PXD053169
type
dataset
label
GEO PXD053169
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-39123454
type
extraction
used array · 1 item
[0]
source:pmid:39123454
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-PXD053169
type
accession_resolution
used array · 1 item
[0]
data:geo:PXD053169
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:39123454
parent_hash
sha256:2ddebbc815eb1ba1c4ed0bf8e2c6ee4dcf5837df2da3eb1e88f5aa265060923f
fork_of
null
gaps array · 7 items
[0]
asset:data:geo:PXD053169 licence not read
[1]
asset:data:geo:PXD053169 not downloaded
[2]
execution.not_run
[3]
review.human_critique
[4]
review.independent_reader
[5]
review.machine_critique
[6]
step:obtain_source_data blocked on data:accession_unresolved
assays array · 3 items
[0] object · 11 fields
role
data_generation
definition_id
western_blot
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 4 items
[0]
sed for protein and miRNA screening. We used Western blotting and Real-Time Quantitative Reverse Transcrip
[1]
associated protein (YAP), were validated via Western blotting. miR-1285-3p was successfully validated as d
[2]
arget Protein Analysis in Tissue Samples via Western Blot The differential protein markers that were i
[3]
, TGM2, and YAP, were analyzed/validated via Western blotting within the two disease groups PDAC and PDAC
order_basis
paper_text_order:519
id
assay:1
[1] object · 11 fields
role
data_generation
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 3 items
[0]
time quantitative polymerase chain reaction (qPCR), the TaqMan Advanced miRNA Assay from Therm
[1]
ding to the manufacturer’s protocol. In this qPCR, the desired cDNA products were amplified an
[2]
thesis from Plasma Samples, and Quantitative Real-Time PCR The selection of the patients from the colle
order_basis
paper_text_order:3294
id
assay:2
[2] object · 11 fields
role
analysis
definition_id
group_comparison
definition_version
f2132e96ae6c7a4e
required_operations array · 4 items
[0]
group_summary
[1]
welch_t
[2]
bootstrap_mean_difference
[3]
group_comparison_anova
support_state
supported
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
Comparisons between experimental groups with normal distributions were performed using one-way ANOVA followed by Tukey’s post hoc test, and pairwise tests were performed using unpaired t-tests. A linear model was fitted to the normalized data, and differential expression was assessed by computing the empirical Bayes statistics.
order_basis
consumes_earlier_output
id
assay:3
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:39123454", "kind": "science-record", "revision": 4, "content_hash": "sha256:40868038158a6ae2b0b541bea9fcfb926c08ead5756f649bbccfc62ae2f8ef44", "created_at": "2026-11-01T20:29:13Z", "updated_at": "2026-11-01T22:54:54Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as Potential New Biomarkers in Patients with Diabetes Mellitus and Pancreatic Adenocarcinoma.", "doi": "10.3390/cancers16152726", "pmid": "39123454", "authors": ["Theodoros Kolokotronis", "Britta Majchrzak-Stiller", "Marie Buchholz", "Vanessa Mense", "Johanna Strotmann", "Ilka Peters", "Lea Skrzypczyk", "Sven-Thorsten Liffers", "Louise Massia Menkene", "Mathias Wagner", "Matthias Glanemann", "Fay Betsou", "Wim Ammerlaan", "Ronny Schmidt", "Christoph Schröder", "Waldemar Uhl", "Chris Braumann", "Philipp Höhn"], "journal": "Cancers", "year": 2024, "abstract": "Early detection of PDAC remains challenging due to the lack of early symptoms and the absence of reliable biomarkers. The aim of the present project was to identify miRNA and proteomics signatures discriminating PDAC patients with DM from nondiabetic PDAC patients. Proteomics analysis and miRNA array were used for protein and miRNA screening. We used Western blotting and Real-Time Quantitative Reverse Transcription polymerase chain reaction (qRT-PCR) for protein and miRNA validation. Comparisons between experimental groups with normal distributions were performed using one-way ANOVA followed by Tukey's post hoc test, and pairwise tests were performed using t-tests. p ≤ 0.05 was considered statistically significant. Protein clusters of differentiation 166 (CD166), glycoprotein CD63 (CD63), S100 calcium-binding protein A13 (S100A13), and tumor necrosis factor-β (TNF-β) were detected in the proteomics screening. The miRNA assay revealed a differential miRNA 1285 regulation. Previously described target proteins of miR-1285 cadherin-1 (CDH-1), cellular Jun (c-Jun), p53, mothers against decapentaplegic homolog 4 (Smad4), human transglutaminase 2 (TGM2) and yes-associated protein (YAP), were validated via Western blotting. miR-1285-3p was successfully validated as differentially regulated in PDAC + DM via qRT-PCR. Overall, our data suggest miRNA1285-3p, TGM2, CDH-1, CD166, and S100A13 as potential meaningful biomarker candidates to characterize patients with PDAC + DM. Data are available via ProteomeXchange with the identifier PXD053169.", "claims": [{"id": "claim-method", "statement": "Comparisons between experimental groups with normal distributions were performed using one-way ANOVA followed by Tukey’s post hoc test, and pairwise tests were performed using unpaired t-tests. A linear model was fitted to the normalized data, and differential expression was assessed by computing the empirical Bayes statistics.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:39123454", "locator": "sections[12] \"2.7. Statistics and Calculations\" paragraph 2", "quote": "Comparisons between experimental groups with normal distributions were performed using one-way ANOVA followed by Tukey’s post hoc test, and pairwise tests were performed using unpaired t-tests."}, {"asset": "source:pmid:39123454", "locator": "sections[8] \"2.3.3. miRNA Profiling Using a Takara Platform\" paragraph 2", "quote": "A linear model was fitted to the normalized data, and differential expression was assessed by computing the empirical Bayes statistics."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The mass spectrometry proteomics data that support the findings of this study have been deposited to the ProteomeXchange Consortium via the PRIDE [1] partner repository with the dataset identifier PXD053169. Our data are available upon reasonable request.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:39123454", "locator": "sections[26] \"notes\" paragraph 1", "quote": "The mass spectrometry proteomics data that support the findings of this study have been deposited to the ProteomeXchange Consortium via the PRIDE [1] partner repository with the dataset identifier PXD053169. Our data are available upon reasonable request."}], "state": "complete"}, {"id": "claim-target-result", "statement": "miRNA-1285 was selected for validation because it had a logFC of 1.25 and was significantly expressed in both resected and unresectable PDAC subgroups.", "kind": "qualitative", "target": null, "evidence": [{"asset": "source:pmid:39123454", "locator": "sections[16] \"3.3. miRNA Microarray Results and Selection of miRNA Targets\" paragraph 4", "quote": "miRNA-1285 with a logFC of 1.25 was selected as the most promising miRNA for validation, as it was significantly expressed in both subgroups of patients with resected and unresectable PDAC."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "partial", "objective": "miRNA-1285 was selected for validation because it had a logFC of 1.25 and was significantly expressed in both resected and unresectable PDAC subgroups.", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:39123454"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "blocked", "blocked_on": "data:accession_unresolved", "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD053169"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD053169"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:obtain_source_data blocked on data:accession_unresolved"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:39123454", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.3390/cancers16152726", "sha256": "sha256:391a5a63d5a3a4ed2e5f2ba587a7c11990d2fd521cdcb66389933608bc9d6356", "bytes": 61916, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.3390/cancers16152726", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC11311671", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:PXD053169", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD053169", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "PXD053169", "version": null, "note": "The mass spectrometry proteomics data that support the findings of this study have been deposited to the ProteomeXchange Consortium via the PRIDE [1] partner repository with the dataset identifier PXD053169. Our data are available upon reasonable request.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The mass spectrometry proteomics data that support the findings of this study have been deposited to the ProteomeXchange Consortium via the PRIDE [1] partner repository with the dataset identifier PXD053169. Our data are available upon reasonable request.", "access_statement_kind": "data_availability_statement", "sample_accessions": [], "sample_count": null, "group_sizes": null, "group_sizes_basis": null, "platform": null, "taxon": null, "title": null, "resolution_checked_at": "2026-11-01T20:16:17Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}], "gaps": ["asset:data:geo:PXD053169 not downloaded", "asset:data:geo:PXD053169 licence not read"]}, "analysis": {"state": "complete", "methods": [{"id": "method-1", "family": "group_comparison", "specific": "anova", "label": "Group comparison", "dsl_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 1.0, "band": "reordered", "quote": "Comparisons between experimental groups with normal distributions were performed using one-way ANOVA followed by Tukey’s post hoc test, and pairwise tests were performed using unpaired t-tests. A linear model was fitted to the normalized data, and differential expression was assessed by computing the empirical Bayes statistics."}}], "targets": [], "gaps": []}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "blocked", "tier": "R4", "blocking_axis": "data", "blocked_on": "data:accession_absent", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: anova."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R4", "reachable": false, "accessions": ["PXD053169"], "resolved_accessions": [], "statements": ["The mass spectrometry proteomics data that support the findings of this study have been deposited to the ProteomeXchange Consortium via the PRIDE [1] partner repository with the dataset identifier PXD053169. Our data are available upon reasonable request."], "basis": "The paper names PXD053169, but the accession does not resolve in the repository (not_in_proteomexchange), so the data cannot be reached from here. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "assets": ["source:pmid:39123454", "data:geo:PXD053169"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:PXD053169"]}, "gaps": ["data:accession_absent"]}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-11-01T19:27:24Z", "independence": "single_reader"}, "evidence_check": {"method": "reordered", "availability": "verbatim"}, "calls": 5, "usage": {"prompt_tokens": 16549, "completion_tokens": 1715, "cached_tokens": 256}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:39123454", "type": "paper", "label": "pmid:39123454"}, {"id": "source:pmid:39123454", "type": "manuscript", "label": "PMID 39123454 full text"}, {"id": "data:geo:PXD053169", "type": "dataset", "label": "GEO PXD053169"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:39123454", "type": "paper", "label": "pmid:39123454"}, {"id": "source:pmid:39123454", "type": "manuscript", "label": "PMID 39123454 full text"}, {"id": "data:geo:PXD053169", "type": "dataset", "label": "GEO PXD053169"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-39123454", "type": "extraction", "used": ["source:pmid:39123454"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-PXD053169", "type": "accession_resolution", "used": ["data:geo:PXD053169"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:39123454", "parent_hash": "sha256:2ddebbc815eb1ba1c4ed0bf8e2c6ee4dcf5837df2da3eb1e88f5aa265060923f", "fork_of": null, "generation": 3}, "gaps": ["asset:data:geo:PXD053169 licence not read", "asset:data:geo:PXD053169 not downloaded", "execution.not_run", "review.human_critique", "review.independent_reader", "review.machine_critique", "step:obtain_source_data blocked on data:accession_unresolved"], "assays": [{"role": "data_generation", "definition_id": "western_blot", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["sed for protein and miRNA screening. We used Western blotting and Real-Time Quantitative Reverse Transcrip", "associated protein (YAP), were validated via Western blotting. miR-1285-3p was successfully validated as d", "arget Protein Analysis in Tissue Samples via Western Blot The differential protein markers that were i", ", TGM2, and YAP, were analyzed/validated via Western blotting within the two disease groups PDAC and PDAC"], "order_basis": "paper_text_order:519", "id": "assay:1"}, {"role": "data_generation", "definition_id": "qpcr", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["time quantitative polymerase chain reaction (qPCR), the TaqMan Advanced miRNA Assay from Therm", "ding to the manufacturer’s protocol. In this qPCR, the desired cDNA products were amplified an", "thesis from Plasma Samples, and Quantitative Real-Time PCR The selection of the patients from the colle"], "order_basis": "paper_text_order:3294", "id": "assay:2"}, {"role": "analysis", "definition_id": "group_comparison", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["Comparisons between experimental groups with normal distributions were performed using one-way ANOVA followed by Tukey’s post hoc test, and pairwise tests were performed using unpaired t-tests. A linear model was fitted to the normalized data, and differential expression was assessed by computing the empirical Bayes statistics."], "order_basis": "consumes_earlier_output", "id": "assay:3"}]}